0.9 % w/v Sodium Chloride Injection, Reblozyl 25 mg powder for solution for injection, Reblozyl 75 mg powder for solution for injection
ACE-536-MF-002
Phase 3 small_molecule active
Quick answer
0.9 % w/v Sodium Chloride Injection, Reblozyl 25 mg powder for solution for injection, Reblozyl 75 mg powder for solution for injection for Anemia associated with myeloproliferative neoplasm (MPN)-associated myelofibrosis (MF) is a Phase 3 program (small_molecule) at Celgene Europe Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Celgene Europe Limited
- Indication
- Anemia associated with myeloproliferative neoplasm (MPN)-associated myelofibrosis (MF)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active